Coca-Cola clarified that Coke Zero and Diet Coke do not contain the sugar replacement called erythritol but instead have aspartame.
According to Coca-Cola’s official website, aspartame is used in some of its products including Coke Zero Sugar, Diet Coke, Diet Coke Feisty Cherry, Diet Barq’s, Fanta Zero, Fresca, Gold Peak Diet Tea, Mello Yello Zero, Minute Maid Light, Pibb Zero, Seagrams Ginger Ale Zero Sugar, and Sprite Zero.
Aspartame provides low or no sugar calories option.
Unlike erythritol, aspartame hasn’t been linked with any serious side effects or health problems.
A recent study draws attention to the harmful effects of erythritol such as linked to causing serious health issues, including the risk of stroke, blood clotting, and heart attack
Erythritol reportedly used to “add bulk or sweeten monk fruit and keto reduced-sugar products.
According to Peace Health, one of the names for sugar alcohols used in foods labeled "sugar-free" or "no sugar added" is erythritol.
It is regarded as having calories and carbohydrates even if it is labeled as "sugar-free". It is said to have negative effects on persons who already have other underlying medical issues because it can raise blood sugar levels.
Erythritol is found naturally in some foods like wine, beer, and even cheese when they ferment.


GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations
What’s the difference between baking powder and baking soda? It’s subtle, but significant
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Anthropic Secures $1.5B AI Venture Backed by Wall Street Giants, Shaking Software Sector
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated
The Beauty Beneath the Expressway: A Journey from Self to Service
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right
UAE Exits OAPEC Amid Shift Toward Independent Oil Strategy and Market Uncertainty
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth 



